Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3732361015 | Gefitinib only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3732362010 | Product containing only gefitinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2839251000001113 | Gefitinib (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2839261000001111 | Gefitinib | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gefitinib | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Gefitinib | Has active ingredient | Gefitinib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Gefitinib | Is a | Product containing gefitinib | true | Inferred relationship | Existential restriction modifier | ||
| Gefitinib | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Gefitinib | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only gefitinib in oral dose form (medicinal product form) | Is a | True | Gefitinib | Inferred relationship | Existential restriction modifier | |
| Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Is a | True | Gefitinib | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR